Cargando…
Iron Metabolism in Cancer
Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though. By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidation, DNA, and protein damages, leading to carcinogenesis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337236/ https://www.ncbi.nlm.nih.gov/pubmed/30591630 http://dx.doi.org/10.3390/ijms20010095 |
_version_ | 1783388206079672320 |
---|---|
author | Wang, Yafang Yu, Lei Ding, Jian Chen, Yi |
author_facet | Wang, Yafang Yu, Lei Ding, Jian Chen, Yi |
author_sort | Wang, Yafang |
collection | PubMed |
description | Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though. By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidation, DNA, and protein damages, leading to carcinogenesis or ferroptosis. Iron also plays profound roles in modulating tumor microenvironment and metastasis, maintaining genomic stability and controlling epigenetics. in order to meet the high requirement of iron, neoplastic cells have remodeled iron metabolism pathways, including acquisition, storage, and efflux, which makes manipulating iron homeostasis a considerable approach for cancer therapy. Several iron chelators and iron oxide nanoparticles (IONPs) has recently been developed for cancer intervention and presented considerable effects. This review summarizes some latest findings about iron metabolism function and regulation mechanism in cancer and the application of iron chelators and IONPs in cancer diagnosis and therapy. |
format | Online Article Text |
id | pubmed-6337236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63372362019-01-22 Iron Metabolism in Cancer Wang, Yafang Yu, Lei Ding, Jian Chen, Yi Int J Mol Sci Review Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though. By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidation, DNA, and protein damages, leading to carcinogenesis or ferroptosis. Iron also plays profound roles in modulating tumor microenvironment and metastasis, maintaining genomic stability and controlling epigenetics. in order to meet the high requirement of iron, neoplastic cells have remodeled iron metabolism pathways, including acquisition, storage, and efflux, which makes manipulating iron homeostasis a considerable approach for cancer therapy. Several iron chelators and iron oxide nanoparticles (IONPs) has recently been developed for cancer intervention and presented considerable effects. This review summarizes some latest findings about iron metabolism function and regulation mechanism in cancer and the application of iron chelators and IONPs in cancer diagnosis and therapy. MDPI 2018-12-27 /pmc/articles/PMC6337236/ /pubmed/30591630 http://dx.doi.org/10.3390/ijms20010095 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wang, Yafang Yu, Lei Ding, Jian Chen, Yi Iron Metabolism in Cancer |
title | Iron Metabolism in Cancer |
title_full | Iron Metabolism in Cancer |
title_fullStr | Iron Metabolism in Cancer |
title_full_unstemmed | Iron Metabolism in Cancer |
title_short | Iron Metabolism in Cancer |
title_sort | iron metabolism in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337236/ https://www.ncbi.nlm.nih.gov/pubmed/30591630 http://dx.doi.org/10.3390/ijms20010095 |
work_keys_str_mv | AT wangyafang ironmetabolismincancer AT yulei ironmetabolismincancer AT dingjian ironmetabolismincancer AT chenyi ironmetabolismincancer |